AMENDMENT TO STANDARD EMPLOYMENT AGREEMENT
EXHIBIT 10.2
AMENDMENT
TO
STANDARD EMPLOYMENT AGREEMENT
This Second Amendment to the Standard Employment Agreement (this Amendment) is dated December 31, 2008 (the Effective Date) and is made to by and between Bioject Inc. (BI) and Bioject Medical Technologies Inc. (BMT) (BI and BMT shall be collectively referred to herein as Bioject), and Christine Farrell, an individual (Employee) (together the Parties).
RECITALS
WHEREAS, the Parties entered into a Standard Employment Agreement on or about January 24, 1997 (the Original Agreement), as amended by the First Amendment to Standard Employment Agreement dated November 8, 2004 (the First Amendment); and
WHEREAS, the Parties now want to amend the Employment Agreement to make clear that Biojects obligations under the Original Agreement, as amended by the First Amendment, are binding on any successor of Bioject.
AGREEMENT
NOW, THEREFORE, for good and valuable consideration, and in consideration of the mutual covenants and conditions herein set forth, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:
1. New Section 11. A new Section 11 is hereby added to the Original Agreement, to read in its entirety as follows:
11. Successors.
(a) Biojects Successors. This Agreement shall be binding upon any successor (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of Biojects business and/or assets and Bioject shall cause any such successor to expressly assume in writing the obligations hereunder as a condition precedent to becoming such a successor. For all purposes under this Agreement, the term Bioject shall include any successor to Biojects business and/or assets which becomes bound by this Agreement.
(b) Employees Successors. This Agreement and all rights of Employee hereunder shall inure to the benefit of, and be enforceable by, Employees personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.
2. No Other Amendments. Except as set forth in Section 1, the terms of the Original Agreement, as amended by the First Amendment, are unchanged and remain in full force and effect.
IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to be duly executed as of the day and year first above written.
BIOJECT INC. | ||
By: | /s/ Ralph Makar | |
Name: | Ralph Makar | |
Title: | President and Chief Executive Officer | |
BIOJECT MEDICAL TECHNOLOGIES INC. | ||
By: | /s/ Ralph Makar | |
Name: | Ralph Makar | |
Title: | President and Chief Executive Officer | |
/s/ Christine Farrell | ||
Christine Farrell |
2